SCHMERTZLER MICHAEL, DIR, reported an open-market or private sale at PTC THERAPEUTICS, INC. involving 5626.000000 shares for an estimated $411710.68. Reported holdings after the transaction were 1349094.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
No officer title
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by Section Six Partners, L.P., of which the Reporting Person is a general partner and limited partner, on May 14, 2026.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $72.02 to $73.01 per share. The Reporting Person hereby undertakes, u…
Represents shares of common stock held by Section Six Partners, L.P. The Reporting Person is a general and limited partner of Section Six Partners, L.P. The Reporting Person disclaims beneficial owner…
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $73.02 to $73.40 per share. The Reporting Person hereby undertakes, u…
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $70.94 to $71.92 per share. The Reporting Person hereby undertakes, u…
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $72.11 to $72.25 per share. The Reporting Person hereby undertakes, u…
0 other filings
0 recent txs